CompletedNot Applicable

OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

France21 participantsStarted 2019-11-14

Plain-language summary

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pituitary compressive adenoma (for experimental group) * pituitary non compressive adenoma Exclusion Criteria: * retinian disease * amblyopia * parkinson disease * pregnant woman

What they're measuring

change of middle deviation

Timeframe: before surgery (= inclusion), 4 months after surgery and 10 months after surgery

Change of visual function index

Timeframe: before surgery (= inclusion), 4 months after surgery and 10 months after surgery

Trial details

NCT IDNCT04074642

SponsorCentre Hospitalier Universitaire de Nice

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-22

View on ClinicalTrials.gov More Pituitary Adenoma trials